![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Population pharmacokinetic (PopPK) modeling and simulation of monthly intramuscular (IM) long-acting rilpivirine (RPV LA) to inform strategies following dosing interruptions in HIV-1 infected subjects
|
|
|
AIDS 2020
Reported by Jules Levin
Stefaan Rossenu1, Martine Neyens1, Rodica Van Solingen-Ristea1, Bryan Baugh2, Herta Crauwels1
1Janssen Pharmaceutica NV, Research & Development, Beerse, Belgium; 2Janssen Pharmaceutica, Research & Development, Titusville, USA
![1001201](../images/100120/100120-2/1001201.gif)
![1001202](../images/100120/100120-2/1001202.gif)
![1001203](../images/100120/100120-2/1001203.gif)
![1001204](../images/100120/100120-2/1001204.gif)
![1001205](../images/100120/100120-2/1001205.gif)
![1001206](../images/100120/100120-2/1001206.gif)
![1001207](../images/100120/100120-2/1001207.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|